Objective: To describe perinatal outcomes achieved with cord occlusion (CO) in monochorionic twins with severe selective intrauterine growth restriction (sIUGR) and abnormal umbilical artery Doppler in the IUGR twin (types II and III). Methods: We studied a consecutive series of 90 cases of sIUGR with abnormal Doppler treated with CO of the IUGR fetus. Abnormal Doppler was defined as continuous (type II, n = 41) or intermittent (type III, n = 49) absent/reversed end-diastolic flow. All cases presented at least one of the following severity criteria: gestational age (GA) <22 weeks, inter-twin estimated weight discordance >35%, reversed end-diastolic umbilical artery flow or ductus venosus pulsatility index >95th centile. We prospectively recorded pregnancy course and perinatal outcome. Results: Median GA at surgery was 20.6 weeks and mean duration 22.4 min. Miscarriage (<24 weeks) occurred in 3.3% (3/90) and preterm delivery <32 weeks in 7.1% (6/84) of continuing pregnancies. GA at delivery was 36.4 weeks and neonatal survival of the larger twin was achieved in 93.3%. Conclusion: In a consecutive series studied by an experienced team, CO in monochorionic twins with severe sIUGR type II or III was associated with delivery >32 weeks in 92.9% and neonatal survival of the normal twin in 93.3% of pregnancies.

Keywords:
Monochorionic pregnancy, Selective intrauterine growth restriction, Cord occlusion, Fetal therapy
1.
Munoz-Abellana B, Hernandez-Andrade E, Figueroa-Diesel H, Ferrer Q, Acosta-Rojas R, Cabero L, et al: Hypertrophic cardiomyopathy-like changes in monochorionic twin pregnancies with selective intrauterine growth restriction and intermittent absent/reversed end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 2007;30:977-982.
2.
Acosta-Rojas R, Becker J, Munoz-Abellana B, Ruiz C, Carreras E, Gratacos E: Twin chorionicity and the risk of adverse perinatal outcome. Int J Gynaecol Obstet 2007;96:98-102.
3.
Lewi L, van Schoubroeck D, Gratacos E, Witters I, Timmerman D, Deprest J: Monochorionic diamniotic twins: complications and management options. Curr Opin Obstet Gynecol 2003;15:177-194.
4.
Gratacos E, Lewi L, Munoz B, Acosta-Rojas R, Hernandez-Andrade E, Martinez JM, et al: A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol 2007;30:28-34.
5.
Chang YL, Chang SD, Chao AS, Hsieh PC, Wang CN, Wang TH: Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler. Prenat Diagn 2009;29:253-256.
6.
Valsky DV, Eixarch E, Martinez JM, Crispi F, Gratacos E: Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas. Semin Fetal Neonatal Med 2010;15:342-348.
7.
Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM: Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. Am J Obstet Gynecol 2000;182:417-426.
8.
Ishii K, Murakoshi T, Takahashi Y, Shinno T, Matsushita M, Naruse H, et al: Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management. Fetal Diagn Ther 2009;26:157-161.
9.
Gratacos E, Carreras E, Becker J, Lewi L, Enriquez G, Perapoch J, et al: Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow. Ultrasound Obstet Gynecol 2004;24:159-163.
10.
Quintero RA, Bornick PW, Morales WJ, Allen MH: Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol 2001;185:689-696.
11.
Chalouhi GE, Marangoni MA, Quibel T, Deloison B, Benzina N, Essaoui M, et al: Active management of selective intrauterine growth restriction with abnormal Doppler in monochorionic diamniotic twin pregnancies diagnosed in the second trimester of pregnancy. Prenat Diagn 2013;33:109-115.
12.
Gratacos E, Ortiz JU, Martinez JM: A systematic approach to the differential diagnosis and management of the complications of monochorionic twin pregnancies. Fetal Diagn Ther 2012;32:145-155.
13.
Gratacos E, Antolin E, Lewi L, Martinez JM, Hernandez-Andrade E, Acosta-Rojas R, et al: Monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic flow (Type III): feasibility and perinatal outcome of fetoscopic placental laser coagulation. Ultrasound Obstet Gynecol 2008;31:669-675.
14.
Peeva G, Bower S, Orosz L, Chaveeva P, Akolekar R, Nicolaides KH: Endoscopic placental laser coagulation in monochorionic diamniotic twins with type II selective fetal growth restriction. Fetal Diagn Ther 2015;38:86-93.
15.
Kuno A, Akiyama M, Yanagihara T, Hata T: Comparison of fetal growth in singleton, twin, and triplet pregnancies. Hum Reprod 1999;14:1352-1360.
16.
Snijders RJ, Nicolaides KH: Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994;4:34-48.
17.
Hecher K, Jauniaux E, Campbell S, Deane C, Nicolaides K: Artery-to-artery anastomosis in monochorionic twins. Am J Obstet Gynecol 1994;171:570-572.
18.
Deprest JA, Audibert F, van Schoubroeck D, Hecher K, Mahieu-Caputo D: Bipolar coagulation of the umbilical cord in complicated monochorionic twin pregnancy. Am J Obstet Gynecol 2000;182:340-345.
19.
Nicolini U, Poblete A, Boschetto C, Bonati F, Roberts A: Complicated monochorionic twin pregnancies: experience with bipolar cord coagulation. Am J Obstet Gynecol 2001;185:703-707.
20.
Valsky DV, Martinez-Serrano MJ, Sanz M, Eixarch E, Acosta ER, Martinez JM, et al: Cord occlusion followed by laser cord transection in monochorionic monoamniotic discordant twins. Ultrasound Obstet Gynecol 2011;37:684-688.
21.
Arduini D, Rizzo G: Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med 1990;18:165-172.
22.
Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
23.
Baschat AA, Gembruch U: The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003;21:124-127.
24.
Hecher K, Campbell S, Snijders R, Nicolaides K: Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 1994;4:381-390.
25.
Bebbington MW, Danzer E, Moldenhauer J, Khalek N, Johnson MP: Radiofrequency ablation versus bipolar umbilical cord coagulation in the management of complicated monochorionic pregnancies. Ultrasound Obstet Gynecol 2012;40:319-324.
26.
Has R, Kalelioglu I, Corbacioglu Esmer A, Ermis H, Dural O, Dogan Y, et al: Bipolar cord coagulation in the management of complicated monochorionic twin pregnancies. Fetal Diagn Ther 2014;36:190-195.
27.
Robyr R, Yamamoto M, Ville Y: Selective feticide in complicated monochorionic twin pregnancies using ultrasound-guided bipolar cord coagulation. BJOG 2005;112:1344-1348.
28.
Lewi L, Gratacos E, Ortibus E, van Schoubroeck D, Carreras E, Higueras T, et al: Pregnancy and infant outcome of 80 consecutive cord coagulations in complicated monochorionic multiple pregnancies. Am J Obstet Gynecol 2006;194:782-789.
29.
Rossi AC, D'Addario V: Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature. Am J Obstet Gynecol 2009;200:123-129.
30.
Huber A, Diehl W, Zikulnig L, Bregenzer T, Hackeloer BJ, Hecher K: Perinatal outcome in monochorionic twin pregnancies complicated by amniotic fluid discordance without severe twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2006;27:48-52.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.